(Q30407057)

English

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

type-1 diabetes

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

Gian Vincenzo Zuccotti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Antonella Amendola

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

A Scaramuzza

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

L Santoro

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Macedoni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Gazzarri

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

G Anselmi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Zanetti

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1530-1536

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916971%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Diabetes and the severity of pandemic influenza A (H1N1) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03449.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30407057&oldid=1980048041"